Rising Incidence of Infectious Diseases Drives the Automated and Rapid Microbiological Tests Market, According to New Report by Global Industry Analysts, Inc.
GIA announces the release of a comprehensive global report on Automated and Rapid Microbiological Tests markets. Global market for Automated and Rapid Microbiological Tests is forecast to reach US$5.9 billion by 2020, driven by increase in outbreaks of new diseases caused by mutant microorganisms, rising healthcare expenditure, and growing need to speed up microbiological testing.
San Jose, California (PRWEB) May 30, 2014
Microbiology is one of the major segments of the diagnostic testing market. Rapid pathogen identification and analysis is gaining importance due to the increase in outbreak of new diseases caused by mutant microorganisms. Rapid and reliable detection of pathogenic bacteria is critical in preventing disease progression and spread. As a result, the growing need to speed up microbiological testing is driving demand for automated and rapid microbiological tests. Another key factor driving growth in the market is rising healthcare expenditure and the ensuing need to enhance the accuracy of medical treatment decisions. Increased use of automated and rapid microbiological tests in the healthcare system will help provide quicker disease management, enable administration of appropriate antimicrobial therapy, and reduce morbidity and mortality rates while simultaneously lowering associated costs. Stringent regulations are additionally helping drive the development of innovative test solutions by providing a clear blueprint for testing requirements, thus catalyzing improvements in production processes.
The boom in demand for automated microbiological tests has been fuelled by the recent advances in DNA probes, monoclonal antibodies, biochips, immunoassays, specimen collection devices, new detection technologies, computers and automation that have permitted the development of versatile and reliable diagnostics. Advanced microbiological procedures not only promise to provide results with the same accuracy as that of the conventional tests, but also significantly enhance sensitivity and specificity of the procedure. With increasing competition, manufacturers are focusing on the development of new, innovative, affordable and easy-to-use tests. Strong growth in the global point-of-care market is additionally driving market opportunities for the use of automated and rapid microbiological tests.
As stated by the new market research report on Automated and Rapid Microbiological Tests, the United States represents the single largest market worldwide. Growth in the country is supported by the growing emphasis on early diagnosis and treatment against a backdrop of rising incidence of infectious diseases. Asia-Pacific is forecast to spearhead global growth with a CAGR of 7.9% over the analysis period. Aging population, economic prosperity, rising healthcare awareness, and increasing healthcare spending by an expanding base of middle class population are factors propelling growth in the region. Automated Identification and Susceptibility Systems represents the largest market segment, while GC/Chlamydia Rapid Tests ranks as the fastest growing segment.
Major players covered in the report include Abbott Laboratories, Abbott Diagnostics, Alere Inc, Becton Dickinson and Company, bioMerieux SA, bioMerieux Inc., Bio-Rad Laboratories Inc., Cellabs Pty Ltd., Celsis International Plc., Coris BioConcept, F Hoffmann-La Roche Ltd., Hologic Gen-Probe Inc., MedMira Inc., Meridian Biosciences Inc., Orasure Technologies Inc., Orion Diagnostica Oy, Quidel Corp., Sekisui Diagnostics, Siemens Healthcare Diagnostics Inc., Thermo Fisher Scientific Inc., and Oxoid Limited, among others.
The research report titled “Automated and Rapid Microbiological Tests: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of market trends, growth drivers, regulations, issues, market challenges, mergers and acquisitions, and other strategic industry activities of major and niche players worldwide. The report provides market estimates and projections in dollars for all major geographic markets, including the US, Canada, Japan, Europe (France, Germany, Italy, UK, Spain, Russia and Rest of Europe), Asia-Pacific (China, India and Rest of Asia-Pacific), Latin America (Brazil and Rest of Latin America), and Rest of World. End-Use Applications analyzed include Clinical Applications (Automated Identification & Susceptibility Systems, Automated Blood Culture Systems, Automated Tuberculosis Systems, Streptococcal Infection Rapid Tests, GC/Chlamydia Rapid Tests and Other Automated & Rapid Microbiological Tests) and Non-Clinical Applications.
For more details about this comprehensive market research report, please visit – http://www.strategyr.com/Automated_And_Rapid_Microbiological_Tests_Market_Report.asp.
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes 1500+ full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.
Global Industry Analysts, Inc.
Web Site: http://www.StrategyR.com/
For the original version on PRWeb visit: http://www.prweb.com/releases/microbiological_tests/rapid_diagnostic_tests/prweb11899515.htm